
Annovis Bio, Inc.
ANVSHealthcare|Biotechnology|US
$0.84
+0.18 (+26.31%)
DCF Value
$0.84
Cash / Share
$0.50
Next Earnings Report
Nov 11, 2026
EPS est. -$0.30
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Nov 5, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (2)
Dec 2027
Est. completion
P3Early Alzheimers Disease
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
NCT06709014n=760
Sep 2029
Est. completion
Recent Press Releases
Annovis Announces Pricing of $21.0 Million Public Offering
Nov 5, 2026 · GlobeNewsWire
Annovis Announces Launch of Proposed Public Offering
Nov 4, 2026 · GlobeNewsWire
Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
Oct 30, 2026 · GlobeNewsWire
Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026
Oct 29, 2026 · GlobeNewsWire
Annovis to Attend the CTAD 2026 with Three Presentations
Oct 22, 2026 · GlobeNewsWire
Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer's Disease
Sep 23, 2026 · GlobeNewsWire
Annovis to Host Corporate Update Webinar on September 2, 2026
Aug 25, 2026 · GlobeNewsWire
Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
Aug 14, 2026 · GlobeNewsWire
SEC Filings (62)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 5, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 4, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 4, 2026 | 8-K | Material event | DocumentIndex |
| Nov 4, 2026 | 8-K | Material event | DocumentIndex |
| Oct 30, 2026 | 8-K | Material event | DocumentIndex |
| Oct 20, 2026 | 8-K | Material event | DocumentIndex |
| Oct 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 7, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Sep 11, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 25, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 29, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 10, 2026 | 8-K | Material event | DocumentIndex |
| Jun 17, 2026 | 8-K | Material event | DocumentIndex |
| May 20, 2026 | 8-K | Material event | DocumentIndex |
| May 20, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| May 19, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 15, 2026 | 8-K | Material event | DocumentIndex |
| Apr 30, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 30, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 10, 2026 | 8-K | Material event | DocumentIndex |
| Apr 9, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 25, 2026 | 8-K | Material event | DocumentIndex |
| Mar 16, 2026 | 8-K | Material event | DocumentIndex |
| Mar 13, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 12, 2026 | 8-K | Material event | DocumentIndex |
| Jan 28, 2026 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Nov 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 28, 2025 | 8-K | Material event | DocumentIndex |
| Oct 28, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Oct 14, 2025 | 8-K | Material event | DocumentIndex |
| Oct 14, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Sep 29, 2025 | 8-K | Material event | DocumentIndex |
| Aug 15, 2025 | 8-K | Material event | DocumentIndex |
| Aug 12, 2025 | 10-Q | Quarterly report | DocumentIndex |